Guardant Health (GH) Operating Leases (2019 - 2026)

Guardant Health has reported Operating Leases for 8 years, with the latest figure at $194.1 million in Q2 2026.

• Quarterly Operating Leases fell 11.23% year-over-year to $194.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $194.1 million (down 11.23% YoY) and the FY2025 annual result came in at $178.5 million, up 8.63% from the prior year.
• Operating Leases declined to $194.1 million in Q2 2026 per GH's latest filing, from $201.1 million in the prior quarter.
• Over five years, Operating Leases peaked at $241.9 million in Q1 2022 and troughed at $164.3 million in Q4 2024.
• A 5-year average of $208.2 million and a median of $208.4 million in 2022 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2022 and 2024: Operating Leases rose 11.32% in 2022, then fell 11.6% in 2024.
• Over 5 years, Operating Leases stood at $210.0 million in 2022, then declined by 11.51% to $185.8 million in 2023, then slipped by 11.6% to $164.3 million in 2024, then grew by 8.63% to $178.5 million in 2025, then rose by 8.75% to $194.1 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $194.1 million, $201.1 million, and $178.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.